Vortioxetine vs placebo in major depressive disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled, phase 3 trials in Japan

Taro Kishi; Kenji Sakuma; Makoto Okuya; Yuki Matsuda; Nakao Iwata

doi:10.1111/pcn.13001

Vortioxetine vs placebo in major depressive disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled, phase 3 trials in Japan

Taro Kishi, Kenji Sakuma, Makoto Okuya, Yuki Matsuda, Nakao Iwata

Psychiatry

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	330-332
Number of pages	3
Journal	Psychiatry and clinical neurosciences
Volume	74
Issue number	5
DOIs	https://doi.org/10.1111/pcn.13001
Publication status	Published - 01-05-2020

All Science Journal Classification (ASJC) codes

Neuroscience(all)
Neurology
Clinical Neurology
Psychiatry and Mental health

Access to Document

10.1111/pcn.13001

Cite this

Kishi, T., Sakuma, K., Okuya, M., Matsuda, Y., & Iwata, N. (2020). Vortioxetine vs placebo in major depressive disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled, phase 3 trials in Japan. Psychiatry and clinical neurosciences, 74(5), 330-332. https://doi.org/10.1111/pcn.13001

@article{21a4b76e447141ac9bedb3d57eb4a295,

title = "Vortioxetine vs placebo in major depressive disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled, phase 3 trials in Japan",

author = "Taro Kishi and Kenji Sakuma and Makoto Okuya and Yuki Matsuda and Nakao Iwata",

year = "2020",

month = may,

day = "1",

doi = "10.1111/pcn.13001",

language = "English",

volume = "74",

pages = "330--332",

journal = "Psychiatry and Clinical Neurosciences",

issn = "1323-1316",

publisher = "Wiley-Blackwell",

number = "5",

}

Vortioxetine vs placebo in major depressive disorder : A systematic review and meta-analysis of double-blind, randomized, placebo-controlled, phase 3 trials in Japan. / Kishi, Taro; Sakuma, Kenji; Okuya, Makoto; Matsuda, Yuki; Iwata, Nakao.

In: Psychiatry and clinical neurosciences, Vol. 74, No. 5, 01.05.2020, p. 330-332.

Research output: Contribution to journal › Letter

TY - JOUR

T1 - Vortioxetine vs placebo in major depressive disorder

T2 - A systematic review and meta-analysis of double-blind, randomized, placebo-controlled, phase 3 trials in Japan

AU - Kishi, Taro

AU - Sakuma, Kenji

AU - Okuya, Makoto

AU - Matsuda, Yuki

AU - Iwata, Nakao

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85082950886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082950886&partnerID=8YFLogxK

U2 - 10.1111/pcn.13001

DO - 10.1111/pcn.13001

M3 - Letter

C2 - 32175646

AN - SCOPUS:85082950886

VL - 74

SP - 330

EP - 332

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 5

ER -